A comprehensive 14-year study of Iranian industrial cities has revealed that air pollution significantly drives healthcare expenditures, with a 10% increase in fine particulate matter (PM2.5) associated with a 3.7% rise in per-capita health spending. The research, published in BMJ Global Health, provides the first city-level evidence linking urban environmental quality to healthcare costs in a middle-income country setting.
Urban factors driving healthcare expenditures in Iranian cities
Elasticity coefficients showing percentage increase in health spending per 10% increase in each factor, 2011-2024
Source: BMJ Global Health, 2024 | Georgian Medical Journal News
Pollution emerges as major cost driver in urban health systems
The ecological panel study tracked 10 industrial cities across Iran from 2011 to 2024, using municipal statistical yearbooks and satellite-derived air quality data. Researchers found that fine particulate matter pollution showed the strongest association with healthcare spending after population ageing, according to the study’s lead authors.
Dr. Mohammad Javad Mohammadi, environmental health researcher at Ahvaz Jundishapur University of Medical Sciences, noted that the findings demonstrate how ambient air pollution creates substantial economic burden on municipal health systems. The study controlled for income, population density, healthcare infrastructure, and green space coverage to isolate pollution’s independent effect.
Beyond PM2.5, population density emerged as another significant driver, with a 10% increase in urban density associated with a 2.8% rise in health expenditures. This relationship suggests that crowding effects and infrastructure strain in rapidly growing cities contribute to healthcare demand, according to findings published in the global health research literature.
Income inequality compounds healthcare cost pressures
When researchers substituted the household-income Gini coefficient for per-capita income in their analysis, income inequality showed a strong positive association with healthcare expenditures. Cities with higher inequality faced disproportionately greater health spending, even after controlling for population demographics and environmental factors.
The Centers for Disease Control and Prevention has documented similar patterns globally, where income disparities translate into differential health outcomes and system costs. In the Iranian cities studied, this relationship held consistently across different model specifications and sensitivity analyses.
Population ageing showed the strongest association of all factors examined, with a 10% increase in the share of residents aged 60 and older linked to a 10.5% increase in per-capita healthcare expenditures. This demographic transition, combined with environmental pressures, creates compounding challenges for municipal health budgets in rapidly industrialising settings.
Green infrastructure shows limited protective effect
Contrary to expectations, urban green space demonstrated only weak associations with healthcare costs, and this relationship proved sensitive to model specification. When researchers included lagged green space variables to account for delayed health benefits, the association lost statistical significance.
The Environmental Protection Agency has documented substantial health co-benefits from urban green infrastructure, but this study suggests that the economic benefits may be more complex to detect at the city level. Quality and accessibility of green spaces, rather than total coverage, may be more important factors in determining health outcomes.
Healthcare facility density per capita showed no statistically significant association with expenditures in any model specification. This finding suggests that supply-side factors may be less important than environmental and demographic demand drivers in explaining variation in municipal health spending across Iranian cities.
Higher ambient PM2.5, urban density, population ageing and income inequality were associated with higher healthcare expenditures in this city-level panel analysis, with pollution showing an elasticity coefficient of 0.37.
— Study authors, BMJ Global Health (2024)
Key takeaways
- Every 10% increase in PM2.5 pollution drives 3.7% higher per-capita healthcare spending in Iranian industrial cities
- Population ageing (elasticity 1.05) and urban density (0.28) compound environmental health cost pressures
- Income inequality independently predicts higher municipal healthcare expenditures beyond individual income effects
Frequently asked questions
How does air pollution increase healthcare costs?
PM2.5 pollution increases respiratory disease, cardiovascular events, and hospital admissions. The study found a 10% increase in fine particulate matter associated with 3.7% higher per-capita health spending across Iranian cities.
Which urban factors drive healthcare spending most?
Population ageing showed the strongest association (elasticity 1.05), followed by PM2.5 pollution (0.37) and population density (0.28). Income inequality also independently predicted higher healthcare expenditures.
Do green spaces reduce healthcare costs?
The study found only weak evidence for cost reduction from urban green space. The association was small (elasticity 0.05) and lost significance when accounting for delayed benefits, suggesting quality and access matter more than total coverage.
The research provides crucial evidence for policymakers designing integrated approaches to urban health challenges. Coordinated strategies combining emission controls, health system strengthening, and improved access to quality green infrastructure may help contain healthcare cost growth in rapidly developing cities facing similar environmental and demographic pressures.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
